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ABSTRACT
Poole, Nina Milan. Ph.D. The University of Memphis. May 2013. The Global
Effects of Tick Saliva on Host Cell Function. Co-Major Professors: Lewis Coons, Ph.D.
and Judith Cole, Ph.D.
Hard ticks, such as Dermacentor variabilis, are obligate ectoparasites that remain
attached to a host for up to 14 days. To sustain this attachment, ticks must secrete
bioactive molecules in their saliva to suppress the host’s immune, inflammatory, wound
healing, and hemostatic responses. Previously, we have shown that tick salivary gland
extract and saliva have cell-specific effects on the function of NIH3T3-L1 fibroblasts and
IC-21 macrophages. Since cell migration is a pre-requisite for tumor invasion and
metastasis, we investigated if saliva has global meaning general effects on the migratory,
invasive, and signaling activities of Saos-2 osteosarcoma and MDA-MB-231 (MB-231)
breast cancer cells. We determined that saliva inhibits Saos-2 and MB-231 migration and
invasion. In Saos-2 cells, this inhibition correlated with suppressed epidermal growth
factor (EGF) activation of Akt, however, only basal extracellular signal-regulated kinase
(ERK) activity was affected in MB-231 cells. Initially, EGF receptor (EGFR) overexpresssion masked the effect of saliva on MB-231 cells, but its ability to inhibit MB-231
migration was comparable to the EGFR inhibitor PD 168393 and MEK inhibitor U0126.
Prostaglandin E2 (PGE2), which is found in high concentration in tick saliva, decreases
fibroblast migration and increases macrophage migration. Therefore we examined if
salivary PGE2 is responsible for the saliva-induced regulation of macrophage and
fibroblast migration by using the PGE2 receptor antagonist, AH 6809. Saliva increased
platelet-derived growth factor (PDGF)-stimulated macrophage migration, a response
reversed by AH 6809. The inhibition of PDGF-stimulated fibroblast migration was also
antagonist-sensitive. Saliva induced macrophages to secrete PGE2, and conditioned
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medium from these cells caused a PGE2 antagonist-sensitive inhibition of stimulated
fibroblast migration. In macrophages, we also showed that saliva decreases the secretion
of the pro-inflammatory chemokine CCL5 and tumor necrosis factor-alpha (TNF-α)
along with its soluble receptor (sTNFRI) through a PGE2-dependent mechanism mediated
by cyclic adenosine monophosphate (cAMP). Our findings indicate that the mechanisms
ticks have evolved to regulate wound healing have generalized effects on cell migratory
activities. These data also demonstrate how salivary PGE2 is utilized to regulate the
activity of macrophages and fibroblasts, cells critically important in wound healing.
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PREFACE
This dissertation is presented as four chapters including two manuscripts. Chapter
one introduces the research and chapter four ties together the results from both
manuscripts. The second chapter contains the manuscript entitled “Effects of tick saliva
on the migratory and invasive activity of Saos-2 osteosarcoma and MDA-MB-231 breast
cancer cells” published in the journal Ticks and Tick-Borne Diseases volume 4 issues 12, February 2013. The third chapter contains the manuscript entitled “Prostaglandin E 2 in
tick saliva regulates macrophage cell migration and cytokine profile” submitted to the
journal Parasites and Vectors, April 2013. Both manuscripts are written in the format
consistent with the guidelines set forth by the professional journal where they have been
published or submitted. Chapters one and four are referenced in accordance to the
guidelines set forth by the journal Ticks and Tick-Borne Diseases.
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CHAPTER 1
Introduction
Ticks (class Arachnida: subclass Acari: superorder Parasitiformes: order Ixodida)
are obligate hematophagous nonpermanent ectoparasites of mammals, birds, reptiles, and
amphibians in at least one stage of their life cycle. Ticks are found on all continents of
the world (Steen et al., 2006), and they transmit more pathogens (viruses, bacteria, and
protozoa) than any other arthropod group (Dennis and Piesman, 2005; Singh and
Girschick, 2003). Worldwide, ticks have medical and veterinary importance (Ullmann et
al., 2008) since they are a common vector for diseases that affect humans, livestock, and
wildlife (Barker and Murrell, 2004; Singh and Girschick, 2003). There are 907 valid tick
species (Guglielmone et al., 2010) but only 10% are disease vectors or compromise the
integrity of the skin during feeding therefore making their host more susceptible to
secondary infections (Jongejan and Uilenberg, 2004). Other injuries associated with tick
parasitism include anemia and exsanguination for heavily parasitized hosts, dermatosis,
toxicosis, paralysis, and anaphylaxis. The success of ticks as disease vectors is due to
their feeding on multiple hosts, wide host ranges, long life spans, and the mechanism and
length of time for feeding (Ullmann et al., 2008). The mechanism utilized by ticks to
acquire a blood meal requires laceration and penetration of the host’s skin with their
mouthparts which remain embedded in the host for minutes or days depending on the
species and life stage.
The phylogenetic analyses of the Acari have proven difficult due to the lack of
fossil evidence, specimens, and molecular data (Ullmann et al., 2008). However, the
superorder Parasitiformes consists of the orders Opiloacarida (mites), Holothyrida
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(mites), Mesostigmata (mites), and Ixodida (ticks). Ticks are monophyletic, and
according to Klompen et al (2010 and 2000), Holothyrida (mites) and Ixodida (ticks)
share a close relationship which suggests the origin of parasitism in ticks evolved from
scavengers and not mesostigmatid-like nest predators. It is understood that Ixodida
consists of 3 families including Argasidae (soft ticks), Ixodidae (hard ticks), and the
monospecific Nuttalliellidae (Guglielmone et al., 2010).
The family Argasidae, termed soft ticks because of their flexible cuticle, consists
of 193 species and 5 genera (Antricola, Argas, Nothoapsis, Ornithodoros, and Otobius)
(Guglielmone et al., 2010). Their cuticle is leathery with prominent mammillae to which
the body muscles attach, and they lack sclerotized shields (Sonenshine, 1991). In
argasids, sexual dimorphism is not present (Coons and Alberti, 1999). Argasids feed on
multiple hosts throughout their lifetime and even within a life stage (Ullmann et al,
2008). These ticks are short-term repetitive feeders that only feed for minutes to hours on
their host. They take up to 2-10 times their unfed body weight in blood depending on the
stage and sex (Balashov, 1972); however, males take up a smaller blood meal than
females. Almost all argasids concentrate the blood meal by excreting excess water and
ions outside their body through paired coxal glands (Mans et al., 2011). After dropping
off the host, a female argasid lays multiple small batches of eggs (Ullmann et al., 2008).
Most soft ticks are nidicolous in behavior and are closely associated with host nests or
burrows.
The Ixodidae or hard ticks, so called because of their heavily sclerotized cuticle,
consists of 702 species and 14 genera (Ambylomma, Anomalohimalaya, Bothriocroton,
Cosmiomma , Cornupalpatum, Compluriscutula, Dermacentor, Haemaphysalis,
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Hyalomma, Ixodes, Margaropus, Nosomma, Rhipicentor, and Rhipicephalus)
(Guglielmone et al., 2010). They have a sclerotized plate on their anterior dorsum termed
a scutum that serves as a site of attachment for body muscles (Sonenshine, 1991). Ixodid
ticks exhibit sexual dimorphism as only females have an alloscutum which consists of
specialized folds that expand when she feeds (Coons and Alberti, 1999). In contrast to
argasids, ixodids feed on 1-3 hosts throughout their lifetime for 3-14 days depending on
the species and life stage (Ullmann et al., 2008). In addition, ixodids only feed once
during each life stage and then molt to the next stage (Ullmann et al., 2008). During
feeding, females can take up as much as 100 times of their unfed body weight (Coons et
al., 1986; Kaufman, 1983; Tatchell, 1967) while males only take in approximately 2
times their unfed body weight. Ixodid ticks lack coxal glands as seen in argasids (Coons
et al., 1986; Kaufman, 1983; Tatchell, 1967). Therefore, the blood meal is concentrated
by excreting excess water and ions through the salivary glands and into the host as
hyposmotic saliva; thus the actual blood meal can be greater than 200 times the unfed
body weight in females (Coons et al., 1986; Kaufman, 1983; Tatchell, 1967). The
feeding process in adult female ixodids is divided into a slow feeding period which takes
up to 7-8 days and a rapid engorgement period of 24-48 hours which only takes place if
the female is inseminated (Coons and Albert, 1999). Once a female ixodid completes a
blood meal and drops off the host, she lays a single batch of eggs that may range in the
tens of thousands depending on the species and dies shortly thereafter (Ullmann et al.,
2008).
The Ixodidae is separated into two divisions: Prostriata and Metastriata
(Sonenshine, 1991). Prostriata contains one genus, Ixodes, and ticks in this division mate
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either on or off the host (reviewed in Kiszweski et al., 2001). Many species of Ixodes
have a limited host range and often show poorly developed host-seeking behavior. The
Metastriata contains all other genera and these ticks mate on the host only after feeding
begins (reviewed in Kiszweski et al., 2001). All metastriate ticks have well developed
host-seeking behaviors with most species ambushing their host and a few actively
seeking their host.
The Nuttallielidae is the most primitive of the 3 tick families and consists of only
1 species, Nuttalliella namaqua, which is considered a living fossil (Mans et al., 2011).
Groups have shown nuttallids share similar characteristics with the other 2 tick families
(Latif et al., 2012; Mans et al., 2011). As in argasids, nuttallids have a multiple host life
cycle (Mans et al., 2011), rapid feeding (Mans et al., 2011), off host mating, a similar
leathery cuticle (El Shoura, 1990; Keirans, 1976), and females lay multiple small batches
of eggs (Latif et al., 2012). Ixodid characteristics include the absence of coxal glands
(Mans et al., 2011), larvae have a sclerotized scutum (Latif et al., 2012), and during all
life stages the ability to climb smooth surfaces (Latif et al., 2012). The monospecific
Nuttallielidae has been instrumental in establishing facts about the other tick families. A
phylogenetic analyses using 16S mitochondrial rRNA and 18S nuclear rRNA placed
Nuttallielidae basal to Argasidae and Ixodidae which further supports the monophyletic
origin of ticks and suggests blood-feeding originated in an argasid-like ancestral tick
lineage (Mans et al., 2011).
Unlike mosquitoes, who insert their proboscis directly into the host’s capillary,
ticks are pool feeders that establish a specialized feeding lesion which fills with blood
from lacerated capillaries. During the feeding process, ticks continuously alternate
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between ingesting blood and salivating into the host (Coons and Alberti, 1999;
Sonenshine, 1991; Kemp et al., 1982). Consequently, ixodid ticks have a very complex
feeding process that requires physical attachment to the host for an extended period of
time in contrast to the short-term feeders, argasids and nuttallids. They secrete a cementlike substance from their salivary glands into the host that hardens to aid attachment to
the host, seals the feeding lesion to prevent fluid loss, and enhances blood sucking by the
pharyngeal pump (Coons and Alberti, 1999; Sonenshine, 1991; Kemp et al., 1982). The
mechanical damage to the host’s skin from the tick’s mouthparts during feeding should
elicit the host’s immune, inflammatory, hemostatic, and wound healing responses as
similar objects of the same size; however these typical responses do not occur. Tick
saliva which contains a cocktail of immunomodulatory, anti-inflammatory, antihemostatic, and anti-angiogenic components is the most well-studied mechanism utilized
by ticks to subvert these host responses (Fontaine et al., 2011; Anderson, 2010; Nuttall
and Labuda, 2008; Brossard and Wikel, 2008; Anderson and Valenzuela, 2008; Steen et
al., 2006; Sauer et al., 1995; Ribeiro, 1995 and 1987). The saliva not only provides a
means by which ticks dampen the host responses to allow feeding until repletion, but it
also permits ticks to transmit a variety of pathogens to humans and animals by enhancing
the pathogenicity of agents, a process referred to as saliva-activated transmission of
pathogens (Nuttall and Labuda, 2004; Jones et al., 1992).
The goal of several studies has been to identify and characterize the molecules in
saliva that modulate host responses. According to Steen et al. (2006), 50 biologically
active salivary components, mostly proteins, have been identified. Tick salivary
component(s) have immunosuppressive effects on cells involved in innate immunity such
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as neutrophil recruitment (Guo et al., 2009), apoptosis (Beaufays et al., 2008), adherence
(Montgomery et al., 2004), and phagocytosis (Ribeiro et al., 1990). Natural killer cell
activity is also decreased (Kopecký and Kuthejlová, 1998 and Kubeš et al., 1994). In
antigen-presenting cells, saliva reduces macrophage cytokine production (Brake et al.,
2012; Chen et al., 2012), phagocytosis (Kramer et al., 2011), co-stimulatory molecule
expression (Brake et al., 2012 and 2010), nitric oxide production (Kopecký and
Kuthejlová, 1998), and inhibits dendritic cell maturation, differentiation, and cytokine
production (Oliveira et al., 2011; Sá-Nunes et al., 2007; Cavassani et al., 2005). There
are molecules in tick saliva that regulate angiogenesis and wound healing to aid feeding
(Hajnická et al., 2011; Francischetti, 2010; McEachron and Mackman, 2009; CarneiroLobo et al., 2009; Francischetti et al., 2005) and that control cell migration by altering
host cell signaling (Poole et al., 2013; Kramer et al., 2011and 2008) and the activity of
chemokine binding proteins (Vančová et al., 2010; Dias et al., 2009; Dѐruaz et al., 2008;
Hajnická et al., 2005; Vančová et al., 2007; Frauenschuh et al., 2007).
In our studies, we used Dermacentor variabilis commonly known as the
American dog tick as our model organism. D. variabilis is a 3-host metastriate tick
(Ullmann et al., 2008), and is the vector for Rocky Mountain spotted fever, tularemia,
and tick paralysis. We have shown that tick salivary constituent(s) inhibit plateletderived growth factor (PDGF)-stimulated fibroblast migration, possibly through the
inhibition of extracellular signal-regulated kinase (ERK) (Kramer et al., 2008). Salivary
gland extract decreases injury repair and growth factor-induced signaling in renal cells,
indicating that cells not involved in dermal wound healing were affected by the
components in tick saliva (Kramer et al., 2008). Tick saliva suppresses the phagocytic
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activity of macrophages but increases PDGF-stimulated macrophage migration (Kramer
et al., 2011). Therefore from these observations, it appears tick salivary constituent(s)
have distinctive and cell-specific effects on cellular activities.
Since we established that tick saliva regulates the migratory activity of cells
crucial to the wound healing response, the first objective of this study was to determine if
the saliva-induced effect on cell migration was global meaning this regulation by saliva
extends to different cell types. Therefore, we measured the effects of saliva on the
migration of mesenchymal Saos-2 osteosarcoma cells and epithelial MDA-MB-231
adenocarcinoma breast cancer cells. These cell lines were selected because they differ in
embryonic origin and their expression of the epidermal growth factor receptor (EGFR),
as this receptor and its downstream effectors are associated with the migratory activity of
different cancer cells (Liu et al., 2012; Gan et al., 2010; Zhou et al., 2006; Price et al.,
1999).
Upon completing these experiments, we focused on cells involved in host
responses that could prevent or alter a tick’s ability to complete a blood meal.
Macrophages are key regulators of the inflammatory and immune responses as they
secrete numerous cytokines that modulate the activity of T lymphocytes. During wound
healing, macrophages trigger the proliferative phase by releasing cytokines and growth
factors such as PDGF into the injury site. PDGF secreted by macrophages, recruits
fibroblasts to the injury where they proliferate, deposit precursors of the extracellular
matrix, and lay down new collagen. Prostaglandin E2 (PGE2), a potent modulator of
inflammation and migration, is found in high concentration in tick saliva. Therefore, our
second objective was to investigate the role of salivary PGE2 on the regulation of IC-21
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murine macrophage and NIH3T3-L1 murine fibroblast migration. The PGE2 in the saliva
of other tick species (Bowman et al., 1996; Urioste et al., 1995; Inokuma et al., 1994;
Ribeiro et al., 1992 and 1985; Higgs et al., 1976) and has been shown to inhibit dendritic
cell differentiation, maturation, and function (Oliveira et al., 2011; Sá-Nunes et al., 2007)
and T lymphocyte proliferation (Inokuma et al., 1994). To our knowledge, the PGE2
content in D. variabilis saliva has not been measured nor evaluated for its effects on
immune or reparative cell function.
From these studies, our goal was to demonstrate that the saliva-induced
modulation of host cell function is not restricted to immune and reparative cells, but
extends globally to cells with similar functions such as the migratory and invasive
activities of metastatic cancer cells. By expanding the scope of our investigation into
PGE2 as the tick salivary constituent responsible for the changes in macrophage and
fibroblast migration, we may establish a potential mechanism ticks utilize to regulate the
type of cells present near the feeding lesion. Our evaluation of the effects of saliva on
macrophage cytokine production will indicate how ticks are able to control host
inflammatory and immune responses that would usually lead to removal or rejection.
Collectively, these studies will highlight the potential mechanisms ticks utilize to regulate
the complex host-parasite interaction. A broader implication of our work is providing
new information that can be used in combating tick-borne agents which are an important
source of emerging and reemerging diseases.
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CHAPTER 2
Effects of tick saliva on the migratory and invasive activity of Saos-2 osteosarcoma
and MDA-MB-231 breast cancer cells
Introduction
Female ixodid ticks such as Dermacentor variabilis have a complex feeding
process that requires physical attachment to the host for an extended period of time.
After establishing a specialized feeding lesion beneath the host’s dermis, ticks alternate
between ingesting blood and secreting saliva into the host (Coons and Alberti, 1999;
Sonenshine, 1991; Kemp et al., 1982). To complete feeding, a tick must subvert the
host’s immune, hemostatic, inflammatory and wound healing responses using the
numerous bioactive compounds in tick saliva (Hajnická et al., 2011; Kramer et al., 2011;
Oliveira et al., 2011; Vančová et al., 2010; Anderson, 2010; Francischetti, 2010;
Carneiro-Lobo et al., 2009; Dias et al., 2009; Guo et al., 2009; McEachron and
Mackman, 2009; Kramer et al., 2008; Brossard et al., 2008; Anderson et al., 2008;
Dѐruaz et al., 2008; Nuttall and Labuda, 2008; Frauenschuh et al., 2007; Sá-Nunes et al,
2007; Vančová et al., 2007; Francischetti, et al., 2005; Cavassani et al., 2004). Previous
studies in our laboratory show that tick salivary gland extract inhibits platelet-derived
growth factor (PDGF)- stimulated fibroblast migration and suggest that the inhibition of
extracellular signal-regulated kinase (ERK) is involved (Kramer et al, 2008). However,
saliva increased PDGF-stimulated macrophage migration without affecting ERK activity
and suppressed their ability to phagocytose which is important for proper wound healing
to occur (Kramer et al., 2011).
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Metastasis is the process whereby cancer cells spread from the primary tumor to
distant locations where secondary tumors develop. Acquiring motility is crucial for
noninvasive cells to become metastatic (Price et. al, 1997). Normal cell migration is a
multi-step process regulated in part by signal transduction. The same signaling proteins
utilized by normal cells to migrate are also used by cancer cells to increase their motility.
The epidermal growth factor receptor (EGFR) and the downstream targets associated
with this receptor such as ERK and Akt/Protein Kinase B can regulate the migratory
activity of cancer cells (Liu et al., 2012; Gan et al., 2010; Zhou et al., 2006; Price et al.,
1999). Since tick saliva constituent(s) modulate the migratory and signaling activities of
cells involved in the wound healing response, we wondered if it had global effects on the
migratory and invasive activities of cancer cells.
In this study, we evaluated the effects of saliva on the migratory, invasive, and
signaling activities of two distinct types of cancer cells. The mesenchymal Saos-2 cells
are a non-transformed cell line derived from a primary osteosarcoma that retain several
osteoblastic properties while the epithelial MDA-MB-231 (MB-231) adenocarcinoma
breast cancer cell line was originally derived from the pleural effusion between the layers
of tissue that line the lungs and chest cavity. Unlike the Saos-2 cells, the highly invasive
MB-231 cells over-express the EGFR (Davidson et al., 1987) and can develop metastases
in nude mice (Price et al., 1990). The use of these two different cell lines in our study
will provide more information of the potential global effects induced by tick saliva on
cell migration.
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Materials and methods
Cell culture
Saos-2 osteosarcoma cells were a generous gift of Dr. Sayed Khundmiri,
University of Louisville School of Medicine, Louisville, KY and were maintained in 25
or 75 cm2 flasks (Corning Inc., Corning, NY) in McCoy’s medium (MediaTech,
Herndon, VA) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin
and 100 μg/ml streptomycin. NIH3T3-L1 dermal fibroblasts were a generous gift of Dr.
Peter Wilden, University of Missouri School of Medicine, Columbia, MO and were
grown in 25 or 75 cm2 flasks in Dulbecco’s modified Eagle’s medium nutrient mixture F12 (DMEM/F12) (MediaTech, Herndon, VA) supplemented with 10% FBS, 100 U/ml
penicillin and 100 μg/ml streptomycin. MDA-MB-231 breast cancer cells were obtained
from American Type Culture Collection (ATCC, Manassas, VA) and maintained in 25
cm2 flasks or 100 mm dishes in Dulbecco’s modified Eagle’s medium (DMEM)
(MediaTech, Herndon, VA) supplemented with10% FBS, 100 U/ml penicillin and 100
μg/ml streptomycin. All cell lines were subcultured weekly using Ca 2+/Mg2+ free Hank’s
balance salt solution (HBSS) and 0.025% trypsin/0.02% EDTA (Mediatech, Herndon,
VA). All cell lines were seeded at a density of 5 x 104 cells/ml.
Collection of tick saliva
Adult male and female ticks were either purchased from the Tick Rearing Facility
at Oklahoma State University or were a generous gift from Dr. Daniel Sonenshine, Old
Dominion University, Norfolk, VA. Male and female ticks were fed on naive female
New Zealand white rabbits (Mrytle’s Rabbitry, Thompson’s Station, TN) for 5-8 days
following protocols approved by The University of Memphis Institutional Animal Care
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and Use Committee. Partially engorged females (80-350 mg) were removed and attached
to a slide with double-sided adhesive tape. Female ticks were injected with 10 μl of
MOPS buffered tick saline pH 7.0 containing 10 mM dopamine / 10 mM theophylline
with 3% DMSO (Needham and Sauer, 1979). Ticks that failed to secrete saliva by 5 min
post-injection were not used. Ticks secreting saliva were injected a total of 3 times in 5
min intervals with TS/MOPS (10 µl) and saliva was collected in a 5, 10, or 25 µl nonheparinized soda lime glass micropipette. Total protein concentration of saliva was
determined using a Bio-Rad Protein Assay based on the method of Bradford (Bio Rad
Laboratories, Hercules, CA) and stored at -20◦C until used.
Western blot
Total protein for Saos-2 and MB-231 cells was quantified using a Bio-Rad Protein
Assay based on the method of Bradford and was diluted in SDS-PAGE sample buffer.
Equal amounts of proteins were separated on 7.5% SDS-PAGE Tris-glycine gels and
transferred to Optitran nitrocellulose membranes (Whatman Inc., Sanford, ME). Blots
were blocked with Super blocking buffer phosphate buffered saline (PBS) (Pierce
Biotechnology, Rockford, IL) containing

0.05% Tween-20 for 1 h then incubated

overnight with mouse anti-EGFR primary antibody (1:1000) (BD Biosciences
Pharmingen, San Diego, CA), and then incubated with 1:1000 HRP-conjugated goat antimouse IgG (Cell Signaling Technology Inc., Beverly, MA). Blots were washed and
developed

with

SuperSignal

West

Pico

Chemiluminescent

Substrate

(Pierce

Biotechnology, Rockford, IL) and images developed on Classic Blue Autoradiography
Film X (Molecular Technologies, St. Louis, MO).
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Cell migration assay
The effects of tick saliva on Saos-2 and MB-231 basal and stimulated migration
were evaluated using blind well chamber assays (Neuro Probe, Gaithersburg, MD). In
brief, confluent monolayers of cells were removed from dishes by incubation for 20 min
with Ca2+/Mg2+ free HBSS and trypsinization for 5 min. Cells were resuspended in
serum-free medium, counted, and diluted to a concentration of 1 x 10 5 cells/ml. The
bottom chamber of the blind well was loaded with either serum-free medium, medium
with 10% FBS or medium with 100 ng/ml epidermal growth factor (EGF) (Bachem
Americas, Torrance, CA) as the chemoattractant. An 8 µm polycarbonate filter without
matrix proteins (Neuro Probe, Gaithersburg, MD) was inserted between the bottom and
upper chambers and the upper chamber was loaded with 100 µl of the cell suspension
pretreated for 30 min with vehicle, saliva (0.4, 0.8, 1.0 or 3.0 µg protein/ml), the EGFR
tyrosine kinase inhibitor PD 168393 (1 µM; Calbiochem-EMD4Biosciences, La Jolla,
CA), the MEK1 and 2 inhibitor U0126 (100 nM; Tocris Bioscience, Minneapolis, MN) or
co-treatments with saliva and inhibitors. After a 4 h incubation at 37◦C in humidified air
with 5% CO2, the non-migratory cells on the upper surface of the filter were removed
with a cotton-tip applicator and the cells on the lower surface of the filter were fixed with
100% methanol and stained with 0.4% crystal violet in 4% ethanol. The filters were
mounted on glass microscope slides and the cells were counted in five random highpower (40x) fields using a Nikon Labophot light microscope. Data were reported as the
percentage of control cells migrating in the absence of chemoattractant.

19

Matrigel invasion assay
The effects of saliva on Saos-2 and MB-231 invasiveness were assessed using a
24-well plate BD BioCoat Matrigel Invasion Chamber (BD Biosciences, Bedford, MA).
This assay consists of inserts containing 8 µm pore size polyethylene terephthalate
membranes coated with a thin layer of matrigel, a reconstituted basement membrane
which prevents non-invasive cells from migrating through the pores of the membrane. In
contrast, invasive cells are able to detach themselves, invade, and migrate through the
matrigel coated membrane. Experiments were performed according to manufacturer’s
instructions which require the use of invasive control cells such as NIH3T3-L1 fibroblast
to determine the invasive potential of test cells. Cells were trypsinized, counted, and
resuspended at 5 x 104 cells/ml and 750 µl of medium with 10% FBS as the
chemoattractant was added to each well. The uncoated polyethylene terephthalate control
or rehydrated matrigel membrane inserts were aseptically transferred to each well and
500 µl of cell suspension treated with vehicle or increasing amounts of saliva (0.1, 0.2 or
0.4 µg protein/ml) was loaded to the upper well. The plate was incubated for 36 h at
37◦C in humidified air with 5% CO2. After the incubation period, the non-invading cells
were removed from the upper surface of the filters with a cotton-tip applicator and the
cells on the lower surface of the matrigel coated or uncoated control inserts were fixed
with 100% methanol, stained with 0.4% crystal violet in 4% ethanol, and counted in five
random high-power (40x) fields using a Nikon Labophot light microscope. Data were
reported as the percentage of control invading cells.
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Cell number assay
Cell number was determined colorimetrically using the CellTiter® AQueous One
Solution Cell Proliferation Assay (Promega, Madison, WI) that utilizes a tetrazolium
compound (MTS) and an electron coupling agent (phenazine ethosulfate). Saos-2 and
MDA-MB-231 cells were cultured in 96-well plates and changed into serum-free medium
with 0.1% bovine serum albumin (BSA) 24 h prior to each experiment. Cells were
treated with vehicle or saliva (0.1, 0.2, 0.4 or 1.0 µg protein/ml) for 0, 24 and 48 h. Then
20 µl of MTS was added to each well and incubated for 2 h. Live cells reduce MTS to a
soluble formazan product that is directly proportional to the number of viable cells. A
standard curve of known cell number was added to the 96-well plate prior to addition of
MTS to determine cell number. Absorbance was read at 490 nm using a Bio-Tek Elx808
Ultra Microplate Reader. After cell number was determined, data were reported as the
percentage of control cells at 0 h.
Phosphoantibody cell-based ELISA (PACE)
ERK and Akt activation were measured using the phosphoantibody cell-based
ELISA (PACE) described in Kramer et al. (2008). Cells grown in 96-well plates were
changed to serum-free medium 24 h prior to each experiment. Cells were pretreated for
30 min with vehicle, saliva (0.1, 0.2, 0.4, 1.0 or 3.0 µg protein/ml), 1 µM EGFR tyrosine
kinase inhibitor PD 168393, 100 nM MEK inhibitor U0126 or co-treatments with saliva
and inhibitors. Stimulated ERK or Akt activity was determined by challenging with 1, 10
or 100 ng/ml EGF for 15 min. Experiments were stopped by adding ice-cold PBS to each
well. Cells were washed once with PBS and fixed in 4% formaldehyde. After blocking
with 5% BSA (anti-Akt antibody) or 5% nonfat dry milk (anti-ERK antibody) in PBS
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containing 0.1% Triton X-100 (PBS-T), the cells were incubated overnight at 4◦C in
activation-specific phospho-Akt (Ser473) antibody (1:500) or phospho-ERK
(Thr202/Try204) antibody (1:8000) (Cell Signaling Technology Inc., Beverly, MA).
Plates were then washed 3 times with PBS-T, incubated for 1 hr with an HRP-conjugated
secondary antibody, and developed with 1-Step Ultra TMB ELISA substrate (Pierce
Biotechnology, Rockford, IL). Absorbance was read at 450 nm using a Bio-Tek Elx808
Ultra Microplate Reader; data were normalized to the absorbance in controls and reported
as the fold change in Akt and ERK activity.
Statistical analysis
PACE data are means ± SEM of 3-4 experiments assayed in triplicate and
performed over several passages of cells. Data were normalized to the absorbance in
vehicle matched controls and reported as the fold change over basal. Cell migration,
invasion, and number data are percentage of control values ± SEM of 3-4 experiments.
Statistical significance was determined by one-way ANOVA; Student Newman-Kuels
and Dunnett’s post tests were used for multiple comparisons employing Graph Pad Prism
version 3.02 Windows (Graph Pad Software, San Diego CA, www.graphpad.com).
Differences in means were considered significant at p≤ 0.05.
Results
To assess the effect of tick saliva on cell migration, we used blind well assays to
measure the cell movement across an uncoated filter with 8 µm pores. Saos-2 and MB231 cells were pretreated with saliva for 30 min then loaded into the upper chamber of
the blind well chemotaxis chamber where the lower chamber was loaded with serum-free
medium or medium containing 10% FBS. After a 4 h incubation, saliva (0.8 µg
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protein/ml) reduced basal Saos-2 migration by 42.2 ± 5.2% (Fig. 1A). FBS increased
Saos-2 cell migration by 38.1 ± 13.5% a response that was dose-dependently reduced by
32.8 ± 12.4 and 51.9 ± 11.2% for 0.4 and 0.8 µg protein/ml respectively (Fig. 1A). Fig.
1B illustrates how saliva decreases the number of migrating Saos-2 cells when compared
to control. Saliva had no effects on MB-231 basal migration; however there was a
significant pro-migratory response (26.1±4.0%) to saliva at 0.4 µg protein/ml (Fig. 1C).
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Fig. 1. Effect of tick saliva on Saos-2 and MDA-MB-231 migration. Saos-2 and MB231 cells were pretreated with vehicle (PBS) or saliva for 30 min, then incubated for 4 h
in the absence or presence of FBS in the lower chamber. (A) Saliva dose-dependently
decreases basal and FBS-simulated Saos-2 migration (a) p<0.05 when compared to
vehicle control only, (b) p<0.01 and (c) p<0.001 when compared to FBS without saliva.
(B) Images represent the saliva-induced inhibition on FBS-stimulated Saos-2 migration
when compared to control. Data are reported as the % control values and are means +
SEM, n=number of times repeated, n=4. (C) Saliva does not inhibit MB-231 migration
but FBS-stimulated migration increases in the presence of tick saliva. Data are means +
SEM, n=3; (a) p<0.05 when compared to FBS without saliva.
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EGF is a growth factor which enhances the migratory activity of numerous cell
types by binding to the EGFR and stimulating its tyrosine kinase activity (Han et al.,
2010; Dise et al., 2008; Price et al., 1999). The EGFR gene is frequently mutated and the
protein is over-expressed in cancer cells (da Cunha Santos et al., 2011; Teng et al., 2011,
Davidson et al., 1987). Since MB-231 cells are reported to over –express the EGFR
(Davidson et al., 1987) and responded differently to saliva than did Saos-2 cells, we first
compared the level of EGFR expression to see if differences in receptor number might be
masking the effects of saliva on the breast cancer cells. Western blot analysis of 10, 20,
and 40 µg protein of whole-cell extracts confirms greater EGFR protein levels (170 kDa)
in MB-231 breast cancer cells than in Saos-2 osteosarcoma cells (Fig. 2A).
A previous study in MB-231 cells has shown that EGF stimulates a potent
migratory response, and inhibition of ERK 1and 2 by the MEK inhibitor, PD 098059
reduces basal migration (Price et. al, 1999). Therefore, we assessed how decreasing
EGFR and ERK activity would affect the ability of saliva to alter MB-231 migration.
Pretreatment for 30 min with saliva decreased basal MB-231 migration by 44.4 ± 8.1%
and 49.8 ± 9.4% for 1.0 and 3.0 µg protein/ml respectively (Fig. 2B). Reducing EGFR
activity with 1µM PD 168393 decreased basal migration by only 27.9 ±5.5%, while cells
treated with both PD 168393 and saliva (3.0 µg protein/ml) decreased basal migration by
68.9 ± 7.6% (Fig. 2B). Similarly, 100 nM U0126 reduced basal migration by 41.7 ±
8.8% while co-treatment with saliva and U0126 reduced migration by 73.8 ± 1.7% (Fig.
2B). Treatment with saliva (0.8 µg protein/ml) or saliva+PD 168393 were more effective
at reducing EGF-stimulated MB-231 migration (48.8 ± 8.1% and 53.0 ± 9.0% of control
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respectively) than PD 168393 alone (58.7 ± 12.3%) when compared to vehicle control
only (Fig. 2B).

Fig. 2. The EGF receptor (EGFR) and ERK activity play a role in regulating the
migration of MB-231 cells. (A) Western blot analysis of 10, 20, and 40 µg protein of
whole-cell extracts demonstrates greater EGFR protein levels in MB-231 breast cancer
cells than in Saos-2 osteosarcoma cells. MB-231 cells were pretreated for 30 min with
vehicle (DMSO), saliva, the EGFR inhibitor PD 168393 (1 µM), the MEK/ERK
inhibitor U0126 (100 nM) or co-treatments with saliva and inhibitors then migration was
measured 4 h later. (B) Tick saliva decreased basal MB-231 migration and both
inhibitors were more effective at reducing basal migration in the presence of saliva than
when used alone. (a) p<0.05 when compared to U0126 alone, (b) p<0.01 when compared
to PD 168393 alone, and (c) p<0.001 when compared to vehicle. (C) Saliva more
effectively decreased EGF-stimulated MB-231 migration than PD 168393 (a) p<0.05 and
(c) p<0.001 when compared to vehicle control only. Data in (B) and (C) are reported as
the % control values and are means + SEM, n=3.
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The ability of the cancer cells to invade the basement membrane and penetrate
healthy neighboring tissue and blood vessels is crucial to the development of metastatic
disease. To evaluate the effects of saliva on the invasive potential of Saos-2 and MB-231
cells, we used a matrigel invasion assay. Matrigel is a gelatinous protein mixture that
resembles the extracellular matrix in composition and stimulates cells to produce
proteases for degradation. Saos-2 and MB-231 cells were pretreated for 30 min with
saliva then loaded into the upper well of the chamber; the lower well of the chamber was
loaded with medium containing 10% FBS as the chemoattractant. After a 36 h
incubation, saliva dose-dependently decreased Saos-2 invasiveness by 38.3 ± 3.9%, 44.6
± 3.8%, and 62.9 ± 2.1% (Fig. 3A). Saliva effectively reduced MB-231 invasiveness by
52.1 ± 4.8%, 33.0 ± 7.8%, and 39.1 ± 5.7% respectively for 0.1, 0.2, and 0.4 µg
protein/ml (Fig. 3B). MB-231 invasion was maximally inhibited by 0.1 µg protein/ml
and increasing saliva concentration produced no greater effects (Fig. 3B). Saliva with the
highest protein concentration reduced the invasiveness of the control NIH3T3-L1
fibroblasts by 60.0 ± 4.0% (Fig. 3C). These data indicate tick saliva reduces FBSstimulated invasion for Saos-2, MB-231, and fibroblasts.
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Fig. 3. Tick saliva inhibits invasiveness of Saos-2 and MB-231 cells. Saos-2, MB-231
and NIH3T3-L1 cells were pretreated with vehicle (PBS) or saliva for 30 min then
exposed to a chemotactic signal provided by 10% FBS for 36 h. The migration of cells
through the matrigel-coated filter was determined 36 h later. (A) Tick saliva dosedependently decreased FBS-stimulated Saos-2 invasiveness. (B) Saliva decreases FBSstimulated MB-231 invasiveness with the maximum effective dose reached with saliva
containing the lower protein concentration. (C) Saliva also dose-dependently decreases
FBS-stimulated invasiveness of the control cells, NIH3T3-L1 fibroblast. Data are
reported as % control invasiveness and are the means ± SEM, n=3 assayed in triplicate.
(c) p< 0.001 compared to vehicle control.

28

One explanation for the decrease in migration and/or invasion is that saliva kills a
percentage of the cells. To test this possibility, we examined the effect of saliva on cell
number using a MTS cell viability assay. There was no change in cell number with the
different amounts of saliva over 48 h (Fig. 4A and B). We used a clonogenic assay to
evaluate cell viability by colony formation which also supported the conclusion that
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saliva had no effect on cell number (data not shown).
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Fig. 4. Saliva does not affect Saos-2 or MDA-MB-231 cell number. (A) Saos-2 and
(B) MB-231 cells were treated with saliva for 0, 24 and 48 h. There was no significant
reduction in cell number, n=3 assayed in triplicate. Data are means ± SEM% of the
control.

Akt and ERK signaling can both mediate growth-factor induced cellular migration
and aberrant regulation of Akt and ERK pathways can contribute to cancer phenotypes
(Liu et al., 2012; Gan et al., 2010; Yoeli-Lerner et al., 2006; Zhou et al., 2006; Osaki et
al., 2004; Hoshino et al., 1999). Based on the observation that saliva inhibited Saos-2
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and MB-231 migration and invasion, we wanted to determine if Akt or ERK signaling
could be affected by tick saliva. To test this hypothesis, we used PACE assays to
determine the effect of saliva on basal and EGF-stimulated kinase activities. Cells were
pretreated for 30 min with increasing concentrations of saliva followed by a challenge
with 1, 10, or 100 ng/ml EGF for 15 min (Fig. 5 and 6A). In Saos-2 cells, saliva (0.4 µg
protein/ml) significantly reduced EGF-stimulated Akt activity by 60.2 ± 0.3% (Fig. 5A)
but had no significant effect on ERK activity. Saliva had no effect on Akt (data not
shown) or EGF-stimulated ERK activity in MB-231 cells (Fig. 6A). Since the salivainduced effects on basal and/or EGF-stimulated MB-231 migration were enhanced by the
EGFR inhibitor PD 168393 and MEK inhibitor U0126, we used these inhibitors to
evaluate the effects of saliva on ERK activity. Pretreatment with saliva (3.0 µg
protein/ml) for 30 min reduced basal ERK activity by 32.7 ± 0.062% (Fig. 6B).
Decreasing EGFR activity with PD 168393 did not significantly reduce ERK activity in
these cells but treatment with both PD 168393 and saliva (3.0 µg protein/ml) reduced
ERK activity by 42.9 ± 0.023% (Fig. 6B). Inhibition of MEK kinase activity by U0126,
reduced ERK activity by 49.2 ± 0.092% which was less than the 74.9 ± 0.062%
reduction produced by both U0126 and saliva (3.0 µg protein/ml) (Fig. 6B).
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Fig. 5. Effect of tick saliva on Akt and ERK activity in Saos-2 cells. (A) Saos-2 cells
were pretreated with vehicle (PBS) or saliva for 30 min then challenged with 1, 10 and
100 ng/ml EGF for 15 min. Saliva (0.4 µg/ml) decreases Akt activation at each
concentration of EGF but significance (p< 0.05) was achieved at 100 ng/ml EGF, (a)
p<0.05 when compared to (0.0 µg/ml) at 100 ng/ml EGF. (B) Saliva has no significant
effect on EGF-activation of ERK or basal activity in these cells. Data in (A) and (B) are
reported as the fold change from vehicle treated cells and are means ± SEM, n=3 assayed
in triplicate.
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Fig. 6. Tick saliva inhibits basal ERK activity and increases the effectiveness of PD
168393 and U0126 in MB-231. (A) MB-231 cells were pretreated with vehicle (PBS) or
saliva for 30 min then challenged with 1, 10 and 100 ng/ml EGF for 15 min. Saliva had
no effect on EGF-induced ERK activation in these cells or a significant effect on basal
activity at each concentration used. (B) Cells were treated with vehicle (DMSO), saliva,
PD168393 (1 µM), U0126 (100 nM) or co-treatments with saliva and inhibitors for 30
min. 3 µg/ml saliva decreased basal ERK activity, a response enhanced by PD 168393
and U0126. Data are reported as fold change in basal ERK activity and are means +
SEM, n=3 assayed in triplicate. (a) p<0.05 when compared to U0126 alone, (b) p<0.01
when saliva 3.0 µg/ml protein compared to vehicle and PD 168393+ saliva 3.0 µg/ml
protein compared to PD 168393 alone, (c) p<0.001 when U0126+ saliva 3.0 µg/ml
protein compared to vehicle.
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Discussion
Ticks have evolved mechanisms to selectively regulate cells involved in the
wound healing response. We have previously shown that tick salivary gland extract
(SGE) inhibited PDGF- stimulated fibroblast migration (Kramer et al., 2008), a process
required for fibroblasts to begin injury repair. Also, SGE reduced injury repair and
growth factor-induced signaling in renal cells, indicating that cells not involved in dermal
wound healing were affected by tick saliva constituents. Tick saliva suppressed the
phagocytic activity of macrophages while enhancing PDGF-stimulated macrophage
migration (Kramer et al., 2011). Thus, saliva appears to have varied and cell-specific
effects on cellular activities including migration.
In this study we evaluated the effects of saliva from D. variabilis ticks on the
migration, invasion, and signaling activities of Saos-2 osteosarcoma and MB-231 breast
cancer cells. Our results show that saliva inhibits FBS-stimulated Saos-2 migration but
elicits a pro-migratory response in the MB-231 cells. Tick saliva contains high
concentrations of lipid modulators such as prostaglandins (Oliveira et al., 2011; Sá-Nunes
et al., 2007; Cavassani et al., 2004; Bowman et al., 1996) that increase migration in Saos2 and MB-231 cells (Zhao et al., 2011; Timoshenko et al., 2003). Therefore it seems
logical that the prostaglandins in tick saliva would elicit a pro-migratory response in both
cells. One explanation for the different effects on migration might be the chemical
composition of the saliva. Although we used saliva with the same total protein
concentration, for each experiment, the concentration of specific protein and lipid
constituent(s) that can modulate cell migration may vary as the pooled saliva was
collected from many ticks of different feedings. However, we do not believe that
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differences in saliva constituents are responsible as SGE and saliva both inhibit fibroblast
migration (Kramer et al, 2008 and Fig. 3C) consistent with reduced wound healing
(Singer and Clark, 1999). Enhanced macrophage migration is consistent with in vivo
studies showing increased numbers of macrophages at the feeding lesion (Szabó and
Bechara, 1999).
An alternative explanation might be inherent differences in the signaling activities
of the cells. Saos-2 and MB-231 cells both express the EGFR that promotes migration
when activated by EGF, but MB-231 cells have substantially more receptor protein than
do Saos-2 cells (Davidson et al., 1987 and Fig 2A). When we increased the dose of
saliva, basal MB-231 cell migration was inhibited, a response that was enhanced by
inhibiting EGFR signaling and ERK activity. These data are consistent with studies
showing that MB-231 migration is EGF- and ERK-dependent (Price et al., 1999). This
suggests that the differences in saliva effects on migration were the result of MB-231
requiring larger doses of saliva to interfere with what appears to be EGFR- and ERKdependent regulation of migration in these cells.
For metastasis to occur, cancer cells must migrate and invade neighboring tissue
and vasculature, a process that requires the degradation of extracellular matrix proteins.
We observed a decrease in FBS-stimulated invasion in saliva-treated Saos-2 and MB-231
cells. While this response could reflect an effect of saliva on the number of viable cells,
there was no impact on cell number even when Saos-2 and MB-231 cells were treated for
48 with saliva. Alternatively, the effect of saliva on invasion may reflect a lower number
of cells migrating. Saliva does suppress FBS-stimulated migration of Saos-2 cells, but a
reduction in the number of cells migrating does not explain the saliva-induced inhibition
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of FBS-stimulated MB-231 invasion as saliva is pro-migratory in these cells. Invasion
requires the activity of matrix metalloproteinases (MMPs) to degrade the extracellular
matrix (Johnsen et al., 1998), and our invasion data, which reflect the ability of cells to
cross an extracellular matrix-coated filter, suggest that MMP activities are suppressed by
tick saliva. In fact, saliva reduced the invasive activity of NIH3T3-L1 fibroblasts in our
study and previous work with these cells has shown that saliva reduces the expression of
(MMP)-2 and 9 (unpublished data). In addition, inhibition of EGF-induced activation of
(MMP)-9 resulted in suppressed migration and invasion of MB-231 cells (Tsai et al.,
2012) adding further support for a salivary constituent(s) inhibiting MMP activity. We
are currently investigating this hypothesis.
Our analysis of Akt and ERK activity in Saos-2 and MB-231 cells supports the
view that the effect of saliva on migration and invasion reflects changes in EGFR
signaling. In the Saos-2 cells, agonist-induced activation of Akt plays a crucial role in cell
migration (Coltella, et al., 2003), and we show that Akt activation by EGF is reduced by
tick saliva. ERK does not appear to play a role in migration in this cell line as saliva had
no significant effect on basal or EGF-stimulated ERK activity. Basal migration of MB231 cells is ERK- dependent but EGF-stimulated migration is PI3K- and PLC-dependent
(Price et al., 1999). Our data show that saliva had no effect on EGF-stimulated Akt and
ERK activity in the MB-231 cells. While our initial experiments showed no effect of
saliva on basal migration or ERK activity in MB-231 cells, this was a function of saliva
dose, not a lack of ERK-dependence. In addition, the ability of the EGFR receptor
inhibitor PD 168393 and the MEK inhibitor U0126 to reduce ERK activity in the MB231 cells support a role for the EGFR-dependent ERK activation as a target for regulation
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by tick saliva. Akt and ERK are both downstream effectors of EGFR-mediated cellular
processes. If saliva is interfering with EGFR signaling, how is Akt or ERK affected while
the other is not. The specificity of the signaling pathway affected when saliva affects
EGFR signaling in these cells is likely or at least in part due to the different signaling
molecules recruited to the receptor. The recruitment of signal molecules and the number
of these molecules will in turn regulate which downstream pathways are activated and the
duration of activation.
In summary, this study provides further insight to how ticks regulate cell
migration, invasion, and signaling which are important processes in controlling host
cellular responses. Our data indicate that tick saliva constituent(s) are not limited to only
regulating cells involved in the wound healing cascade but can modulate the migratory
and invasive activities of other host cells such as cancer cells by interfering with signal
transduction.
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CHAPTER 3
Prostaglandin E2 in tick saliva regulates macrophage cell migration and cytokine profile
Background
Ixodid ticks such as Dermacentor variabilis are obligate blood-sucking
ectoparasites that physically attach to their host for several days to feed until repletion.
The cutting action of the chelicerae, insertion of hypostome, and the rupturing of blood
vessels [1-3] all result in localized damage to the host’s epidermis and dermis. This
mechanical damage to the host’s skin should elicit the host’s immune, inflammatory,
hemostatic, and wound healing responses resulting in removal or rejection of the tick; but
this is not the case. Instead, ticks use a cocktail of bioactive molecules in their saliva to
evade these host responses [4-12].
Tick saliva has been shown to regulate the migratory activities of distinct cell
types by modulating cell signaling [13-15] and the activity of chemokine binding proteins
[16-21]. Tick salivary constituent(s) have suppressive effects on innate immunity by
regulating neutrophil recruitment [22], adherence [23], phagocytosis [24], and apoptosis
[25] and natural killer cell activity [26-27]. In antigen-presenting cells, saliva reduces
macrophage cytokine production [28-29], co-stimulatory molecule expression [28,30],
phagocytosis [14], and nitric oxide production [26] and inhibits dendritic cell
differentiation, maturation, and cytokine production [31-33]. Tick saliva also contains
molecules that control host angiogenesis and wound healing to aid feeding [34-38].
Prostaglandins are among the most abundant bioactive molecules in tick saliva
[reviewed in 39]. Prostaglandin E2 (PGE2), which increases vasodilation [40] and
decreases inflammation by regulating cytokine production [41-45], is found in high
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concentration in tick saliva [39,46-50]. The exact role(s) of prostaglandins in tick saliva
have not all been identified but salivary PGE2 has been shown to inhibit dendritic cell
differentiation, maturation, and cytokine production [31-32] and T lymphocyte
proliferation [47].
To complete feeding, ticks must control the activities of immune and reparative
cells in the feeding lesion. PGE2 modulates the migratory activity of macrophages [51]
and fibroblasts [52-54]. We have previously demonstrated that tick salivary gland extract
(SGE) and saliva have different effects on platelet-derived growth factor (PDGF)stimulated fibroblast [15] and macrophage [14] migration. Since PGE2 regulates
macrophage and fibroblast migration, in this study we investigate if D. variabilis salivary
PGE2 modulates the migratory activity of IC-21 murine macrophages and NIH3T3L1murine fibroblasts by using the PGE2 receptor antagonist AH 6809. We also use this
approach in evaluating the effects of salivary PGE2 on IC-21cytokine secretion. IC-21
cells were used in this study because they are a continuous monoclonal murine
macrophage-like cell line which is very similar to macrophages in morphology [55].
They also have phagocytic and cytolytic activities [56], express platelet-activating factor
receptors [57], and can be activated by lipopolysaccharide (LPS) via Toll-like receptor 4
(TLR4) [55].
Methods
Cell culture
IC-21 murine peritoneal macrophages were maintained in 25 cm2 flasks or 100
mm dishes in RPMI 1640 (MediaTech, Herndon, VA) supplemented with 10% fetal
bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml streptomycin. Macrophages
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were subcultured weekly using Ca2+/Mg2+ free Hank’s balanced salt solution (HBSS)
(Mediatech, Herndon, VA) and seeded at a density of 5 x 104 or 6 x 104 cells/ml.
NIH3T3-L1 murine dermal fibroblasts were grown in 25 or 75 cm2 flasks in Dulbecco’s
modified Eagle’s medium nutrient mixture F-12 (DMEM/F12) (MediaTech, Herndon,
VA) supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin, and
were subcultured weekly using Ca2+/Mg2+ free HBSS and 0.025% trypsin/0.02% EDTA
(Mediatech, Herndon, VA) then seeded at a density of 5 x 104 cells/ml.
Collection of tick saliva
Adult male and female ticks were purchased from Etco Services, Inc (Henderson,
NC) and maintained in 96% humidity with a saturated K2SO4 solution at room
temperature. Ticks were fed on adult female New Zealand white rabbits (Harlan
Laboratories, Prattville, AL) for 5-8 days following protocols approved by The
University of Memphis Institutional Animal Care and Use Committee. Partially
engorged females (70-350 mg) were removed and attached to a microscope slide with
double-sided adhesive tape. Female ticks were injected with 10 μl of MOPS buffered
tick saline (pH 7.0) containing 10 mM dopamine / 10 mM theophylline with 3% dimethyl
sulfoxide (DMSO) [58]. Ticks that did not salivate 5 min post-injection were not used.
Ticks salivating were injected a total of 3 times in 5 min intervals and saliva was
collected in a 25 µl non-heparinized soda lime glass micropipette, kept on ice, and
pooled. Total protein concentration of saliva was determined using a Bio-Rad Protein
Assay based on the method of Bradford (Bio Rad Laboratories, Hercules, CA) and stored
at -20◦C until used.
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PGE2 measurement
To determine the amount of PGE2 in D. variabilis saliva and how saliva affects
the amount of PGE2 secreted by macrophages, a competitive PGE2 Enzyme Immunoassay
(EIA) Express kit (Cayman Chemical, Ann Arbor, MI) was used. Macrophages were
cultured at a density of 5 x 104 cells/well in 24-well plates for 5 days and changed to
medium containing 2% FBS 24 h prior to the experiment. Cells were treated with vehicle
phosphate buffered saline (PBS) or saliva (1.2 or 3.6 μg protein/ml) for 18 h. The
conditioned medium was collected then stored at -80◦C and PGE2 content was measured
according to manufacturer’s instructions. Absorbance was read at 405 nm using a BioTek Elx808 Ultra Microplate Reader. A standard curve linearized using a logit
transformation and a linear regression fit was used to determine PGE 2 concentrations.
Cell migration assay
The effects of salivary PGE2 on macrophage and fibroblast migration were
assessed using blind well chemotaxis chamber assays (Neuro Probe, Gaithersburg, MD).
Macrophages grown to confluence in 100 mm dishes were incubated for 15 min with
Ca2+/Mg2+ free HBSS. Cells were removed from surface by pipetting and then
resuspended in serum-free medium, counted, and diluted to a concentration of 1 x 10 5
cells/ml. Confluent fibroblasts were removed from flasks by incubation for 15 min with
Ca2+/Mg2+ free HBSS and trypsinization for 5 min. Cells were also resuspended in serumfree medium, counted, and diluted to a concentration of 1 x 10 5 cells/ml. The lower
chamber of the blind well (Neuro Probe, Gaithersburg, MD) was loaded with either
serum-free medium or medium with 100 ng/ml (PDGF-BB) (ProSpec-Tany TechnoGene
Ltd, East Brunswick, NJ) as the chemoattractant. An 8 µm uncoated polycarbonate filter
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(Neuro Probe, Gaithersburg, MD) was placed between the lower and upper chambers of
each blind well. The upper chamber was loaded with 100 µl of the macrophage
suspension pretreated for 30 min with vehicle (DMSO), saliva (2.4 µg protein/ml), or
PGE2 (1 µM; Cayman Chemical, Ann Arbor, MI) in the absence or presence of the E and
D prostanoid (EP and DP) receptor antagonist AH 6809 (10 µM; Cayman Chemical, Ann
Arbor, MI). For the fibroblast suspensions, 30 min pretreatments consisted of vehicle
(DMSO), saliva (2.4 µg protein/ml), PGE2 (1 µM), or conditioned medium (CM) from
macrophages treated with saliva (2.4 µg protein/ml) for 18 h (to allow PGE2 to
accumulate) in the absence or presence of AH 6809. The blind wells were incubated for
4 h at 37◦C in humidified air with 5% CO2. After the incubation period, the non-invading
cells were removed from the upper surface of the filters with a cotton-tip applicator. The
filters were placed upside-down on a microscope slide and the cells were fixed with
100% methanol, stained with 0.4% crystal violet in 4% ethanol, and counted in five
random high-power (40x) fields using a Nikon Labophot light microscope (Nikon,
Melville, NY). Data were reported as the percentage of control cells migrating in 4 h.
Cytokine array
To evaluate the effects of PGE2 in the saliva-induced changes on macrophage
cytokine secretion we used the RayBio ® Mouse Cytokine Antibody Array (Catalog #
AAM-CYT-1-8) RayBiotech, Inc., Norcross, GA) which simultaneously detects 22
cytokines. Macrophages were cultured at a density of 5 x 104 cells/ml in 6-well plates
and grown to confluence. Twenty-four hours prior to the experiment, cells were changed
to medium containing 2% FBS. Cells were treated with vehicle (DMSO), saliva (2.4 µg
protein/ml), 10 µM AH 6809, saliva+AH 6809, 0.76 μg/ml lipopolysaccharide (LPS)
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(InvivoGen, San Diego, CA), or saliva+LPS for 18 h. LPS is a Gram-negative bacteria
toxin which activates macrophages through Toll-like receptor 4 (TLR4). The conditioned
medium was collected, and the cytokine content for each sample was determined
according to manufacturer’s instructions. Arrays were developed with kit detection
buffer and exposed to Classic Blue Autoradiography Film X (Molecular Technologies,
St. Louis, MO) for 0.5, 2.5, 1, and 5 min. The intensities of signals for each cytokine
were quantified by densitometry using ImageJ version 1.46 Windows (National Institutes
of Health, Bethesda, MD, http://rsb.info.nih.gov/ij/). The vehicle-treated array was used
as the reference array to which the signals of the other arrays were normalized. Data are
reported as relative expression levels for each exposure time.
Mouse interleukin-1 beta (IL-1β) enzyme-linked immunosorbent assay (ELISA)
To evaluate the effects of saliva on IL-1β secretion, we used a RayBio ® Mouse
IL-1β ELISA Kit (Catalog # ELM-IL1beta-001 RayBiotech, Inc, Norcross, GA).
Macrophages were cultured at a density of 5 x 104 cells/well in 24-well plates and grown
until confluent. The cells were changed to medium containing 2% FBS 24 h prior to the
experiment. Macrophages were treated with vehicle (PBS) or saliva (1.2 or 3.6 μg
protein/ml) and then stimulated for 18 h with 0.76 μg/ml LPS. The cells were then pulsed
with 5 mM adenosine triphosphate (ATP) (activator of purinergic receptor P2X7) for 20
min and cultured for an additional 3 h. The conditioned medium was collected then
stored at -80◦C and IL-1β content was measured according to manufacturer’s instructions.
Absorbance was read at 450 nm using a Bio-Tek Elx808 Ultra Microplate Reader; data
were normalized to the absorbance in controls and reported as the fold change in IL-1β
secretion.
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Cyclic adenosine monophosphate (cAMP) measurement
A cAMP competitive EIA assay kit (Cayman Chemical, Ann Arbor, MI) was
utilized to determine intracellular cAMP concentrations. Macrophages were cultured at a
density of 5 x 104 cells/well in 24-well plates for 5 days. Cells were washed with serumfree medium and then cultured in RPMI with 0.5 mM 3-Isobutyl-1-methylxanthine
(IBMX) (Sigma-Aldrich, St. Louis, MO) for 30 min. Macrophages were then pre-treated
with AH 6809 for 15 min and challenged with vehicle (DMSO), saliva (1.2 and 3.6 μg
protein/ml), or 3 µM PGE2 for 7.5 min. Cells were lysed in 0.1 M HCL at room
temperature for 20 min and dissociated by pipetting, and samples were collected and
centrifuged at 1000 xg for 10 min at room temperature. Cyclic AMP determination was
performed according to manufacturer’s instructions. Absorbance was read at 405 nm
using a Bio-Tek Elx808 Ultra Microplate Reader, and a standard curve was linearized
using a logit transformation and a linear regression fit was used to determine cAMP
concentrations.
Statistical analysis
PGE2 and cAMP data are means ± standard errors of means (SEM) of 3
experiments assayed in duplicate performed over several passages of cells. Cell
migration data are percentage of control values ± SEM of 3 experiments. Data for the
cytokine array are presented as means ± SEM normalized to the vehicle treated array and
reported as relative expression levels determined by densitometry for 2 exposure times.
Statistical significance was determined by one-way ANOVA; Student Newman-Kuels
post test was used for multiple comparisons employing Graph Pad Prism version 3.02
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Windows (Graph Pad Software, San Diego CA, www.graphpad.com). Differences in
means were considered significant at p≤ 0.05.
Results
Tick saliva increases macrophage PGE2 secretion
PGE2 is one of the most important prostanoids that plays roles in both anti- and
pro-inflammatory responses. We used a PGE2 EIA assay to measure the effects of tick
saliva on macrophage PGE2 secretion. Cells were treated for 18 h with vehicle (PBS) or
saliva (1.2 or 3.6 μg protein/ml). Saliva dose-dependently increased macrophage PGE2
secretion with significance reached at 3.6 μg protein/ml. Saliva (3.6 μg protein/ml)
increased macrophage secretion of PGE2 from 0.1 ± 0.04 to 29 ± 4 ng/ml (Figure 1).
Since PGE2 is found in the saliva of many tick species [31-32,39,46-50], we determined
the total PGE2 concentration of the pooled D. variabilis saliva used in these experiments
was 352 ± 9 ng/ml (Figure 1). We used 12 ul/ml of the pooled saliva to deliver 3.6 μg
protein/ml. Therefore if the PGE2 from the tick saliva is still present in our sample after
18 h, it only accounts for approximately 1.2% of the total PGE2 in the sample.
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Figure 1. Tick saliva causes PGE2 secretion by macrophages. Cells were treated with
vehicle (PBS) or saliva for 18 h. Saliva dose-dependently increased macrophage
secretion of PGE2 reaching signifigance (p<0.05) at 3.6 μg protein/ml, (*) p<0.01 when
compared to vehicle control. The PGE2 concentration of the pooled saliva used for all
experiments was 352 ± 9 ng/ml which was diluted to deliver 3.6 μg protein/ml. If still
present in the sample, the PGE2 from the pooled saliva would only account for
approximately 1.2% of the total PGE2. Data are means ± SEM, n= 3 assayed in duplicate.
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Salivary PGE2 regulates macrophage and fibroblast migration
To determine the role of PGE2 in the effects of saliva on macrophage migration,
we utilized blind well chemotaxis chamber assays. Cells were pretreated with vehicle
(DMSO), saliva (2.4 µg protein/ml), or 1 µM PGE2 in the absence or presence of 10 µM
AH 6809 for 30 min then loaded into the upper chamber. The lower chamber was loaded
with medium for basal migration or medium containing 100 ng/ml PDGF for stimulated
migration. PDGF increased the total number of cells migrating by (264 ± 33%) an effect
enhanced by saliva consistent with previous observations in our lab [14] (Figure 2A).
The saliva-induced increase in PDGF-stimulated macrophage migration was similar to
the increase induced by PGE2 (Figure 2A). The PGE2 receptor antagonist AH 6809
significantly reduced the stimulatory effects of saliva by (53 ± 30%) (Figure 2A). This
reduction was similar to the effects observed in cells treated with PGE2 in the presence of
the receptor antagonist (58 ± 32%) (Figure 2A) which suggests the saliva-induced
increased in macrophage migration was mediated by PGE 2.
Fibroblast migration is inhibited by PGE2 [52-54], saliva [13], and SGE [15].
Therefore, we treated fibroblasts with saliva (2.4 µg protein/ml) in the presence or
absence of 10 µM AH 6809 for 4 h to determine if the PGE2 content in D. variabilis
saliva is responsible for this inhibition. We also treated these cells with conditioned
medium from macrophages treated with saliva (2.4 µg protein/ml) for 18 h, since saliva
induces macrophages to secrete substantial amounts of PGE 2 (Figure 1). The number of
fibroblasts migrating in response to PDGF (346 ± 40%) was significantly reduced by
saliva to (88 ± 11%) and conditioned medium from saliva-treated macrophages to (156 ±
31%) (Figure 2B). The inhibitory effects of saliva and macrophage conditioned medium
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were similar to that of PGE2 and were antagonized by AH 6809 (Figure 2B). This
antagonism partially restored the migration of the saliva-treated cells (55 ± 17%) while
there was full restoration in the cells treated with conditioned medium from saliva-treated
macrophages (94 ± 21%) when compared to the PDGF-stimulated cells (Figure 2B).
These effects indicate PGE2, at least in part, was responsible for the inhibition (Figure
2B).
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Figure 2. Saliva-induced effects on macrophage and fibroblast migration are PGE2
receptor antagonist-sensitive. (A) Macrophages were pretreated for 30 min with
vehicle (DMSO), saliva (2.4 µg protein/ml), or PGE2 (1 µM) in the absence or presence
of the PGE2 receptor antagonist AH 6809 (10 µM), and then incubated for 4 h. PDGF
increased the number of cells migrating, an effect enhanced by saliva and PGE2, (**)
p<0.001 and (*) p<0.01 when compared to PDGF treatment only. These effects were
reversed by AH 6809, (**) p<0.001 when saliva treatment was compared to saliva + AH
6809 and when PGE2 was compared to PGE2 + AH 6809. (B) Fibroblast were pretreated
for 30 min with vehicle (DMSO), saliva (2.4 µg protein/ml), PGE2 (1 µM), or
conditioned medium from macrophages treated with saliva for 18h in the absence or
presence of the AH 6809 (10 µM) using PDGF as the chemoattractant. After 4 h, saliva,
PGE2, and saliva-treated macrophage conditioned medium decreased fibroblast migration
(CM), (**) p<0.001 when compared to PDGF treatment only. The effects of saliva were
partially reversed by AH 6809; however the receptor antagonist fully restored the
migration of cells treated with conditioned medium of saliva-treated macrophages (CM)
similar to that of PGE2 in the presence of AH 6809, (**) p<0.001 when PGE 2 was
compared to PGE2 + AH 6809 and when CM was compared to CM + AH 6809, (#)
p<0.05 when saliva was compared to saliva + AH 6809. Data are reported as the %
control values and are means + SEM, n=3.
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Tick saliva decreases macrophage cytokine secretion, a response sensitive to the
PGE2 receptor antagonist AH 6809
Macrophages regulate the inflammatory and cellular immune responses by
producing cytokines which influence the activity of lymphocytes. The pro-inflammatory
cytokines tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), IL-1 beta (IL-1β),
and PGE2 are mediators of the inflammatory response [59]. In macrophages, PGE2 has
been shown to have inhibitory effects on TNF-α and IL-12 production but enhances the
production of IL-6 [41-42] which has both pro and anti-inflammatory effects. We used
the RayBio ® Mouse Cytokine Antibody Array to simultaneously test the effects of saliva
on LPS-stimulated secretion of 22 cytokines and the role of PGE 2 in any saliva-induced
changes in cytokine secretion. Saliva (2.4 µg protein/ml) significantly inhibited the
relative expression levels of secreted pro-inflammatory cytokines Rantes (CCL5) and
TNF-α along with the soluble form of its receptor TNF Receptor I (sTNFRI) (Figure 3A
and B). Saliva also inhibited LPS-stimulated secretion of these cytokines (Figure 4A and
B). IL-1β is produced by activated macrophages, and this pro-inflammatory cytokine is
an important mediator of the inflammatory response. However, using a mouse IL-1β
ELISA Kit, we show saliva increased LPS-stimulated secretion of IL-1β by
approximately 1.5 fold when compared to the vehicle control (Figure 5). Saliva had no
significant effects on IL-6 and IL-12p40p70 cytokines which also regulate inflammation
(Figure 3 and 4). The inhibitory effects of saliva on CCL5, sTNFRI, and TNF-α, were
significantly reversed by AH 6809 (Figure 3A and B) which implicates the involvement
of PGE2 in these effects.
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Figure 3. Saliva-induced decreases of CCL5, sTNFR1, and TNF-α secretion by
macrophages are PGE2 receptor antagonist-sensitive. Cells were treated with vehicle
(DMSO), saliva (2.4 µg protein/ml), AH 6809 (10 µM), or saliva+AH 6809 for 18 h. (A)
Saliva reduced the relative expression levels of secreted CCL5, soluble TNF Receptor I
(sTNFR1), and TNF-α which was reversed by AH 6809. (B) Image of blots exposed to
film for 2.5 min corresponding to the treatments in (A), cylinder= CCL5, oval= sTNFR1,
and rectangle= TNF-α, (**) p<0.001 when compared to vehicle control and when saliva
was compared to saliva+AH 6809. Data are means ± SEM normalized to the vehicle
treated array reported as relative expression levels determined by densitometry for 1 and
2.5 min exposure times.
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Figure 4. Saliva reduces LPS-stimulated cytokine secretion by macrophages. Cells
were treated with vehicle (DMSO), saliva (2.4 µg protein/ml), LPS, or saliva + LPS for
18 h. (A) Saliva significantly reduced the relative expression levels of CCL5, soluble
TNF Receptor I (sTNFRI), and TNF-α at 0.5 and 1 min exposure times. (B) Image of
blotss exposed to film for 1 min corresponding to the treatments in (A), cylinder= CCL5,
oval= sTNFRI, and rectangle= TNF-α, (#) p<0.05 when compared to vehicle control and
when LPS was compared to LPS + saliva. Data are means ± SEM normalized to the
vehicle treated array reported as relative expression levels determined by densitometry
for 0.5 and 1 min exposure times.

56

Figure 5. Tick saliva increases IL-1β secretion by macrophages. IL-1β is a proinflammatory cytokine produced by activated macrophages. Cells were treated with
vehicle (PBS) or saliva (1.2 or 3.6 μg protein/ml) and then stimulated for 18 h with 0.76
μg/ml LPS. The cells were then pulsed with 5 mM ATP for 20 min and cultured for an
additional 3 h. Surprisingly, saliva dose-dependently increased IL-1β secretion but
significance (p< 0.05) was achieved at 3.6 μg protein/ml, (*) p<0.05 when compared to
vehicle. Data are means ± SEM, n= 3 assayed in duplicate.
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Tick saliva mimics PGE2-stimulated intracellular cAMP production
When PGE2 binds to G protein-coupled receptors EP2/ EP4, the effects are
mediated through increases in the second messenger cAMP. In macrophages, activation
of PGE2 receptors are associated with increased migration [51] and inhibition of proinflammatory cytokines [41-42,60-61]. Therefore, we used a cAMP EIA assay to
examine how the saliva-induced effects on macrophage migration and cytokine secretion
correlate with changes in intracellular cAMP levels. After 7.5 min, saliva (3.6 μg
protein/ml) and 3 µM PGE2 significantly increased cAMP production 62 ± 9 and 87 ± 16
pmol/ml respectively (Figure 6). The stimulatory effects of saliva and PGE2 were both
substantially reversed by the receptor antagonist which decreased cAMP concentrations
to 45 ± 17 and 17 ± 2 pmol/ml respectively (Figure 6). This suggests that the PGE2 in
tick saliva binds receptors EP2/ EP4 and mediates its effects through increases in
intracellular cAMP production in the macrophages.
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Figure 6. Tick saliva increases intracellular cAMP levels in macrophages. Cells
were pretreated with AH 6809 (10 μM) for 15 min and challenged with vehicle (DMSO),
saliva (1.2 and 3.6 μg protein/ml), or PGE2 (3 µM) for 7.5 min. Saliva dose-dependently
increased macrophage intracellular cAMP production and signifcance (p<0.05) was
achieved at 3.6 μg protein/ml with stimulatory effects similar to that of PGE2, (**)
p<0.001 when compared to vehicle control. The stimulatory effects were reversed by AH
6809, (*) p<0.01 when PGE2 was compared to PGE2 + AH 6809 and when saliva was
compared to saliva + AH 6809. Data are means ± SEM, n= 3 assayed in duplicate.
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Discussion
To sustain physical attachment for several days, ixodid ticks have evolved to
produce saliva which contains biologically active molecules that modulate their host’s
immune, inflammatory, hemostatic, and wound healing responses. We have previously
shown that tick salivary constituent(s) have differential effects on the migratory and
signaling activities of fibroblasts and macrophages [13-15]. Both cells are important in
the wound healing cascade; however macrophages are also key regulators of the
inflammatory and immune responses. In wound healing, they phagocytose apoptotic
neutrophils which limit their cytotoxic contents from spilling and damaging surrounding
tissue [62-63]. Macrophages (M2) also trigger the proliferative phase of wound healing
by secreting cytokines and growth factors such as PDGF which recruits fibroblasts to the
site of injury [64]. The cytokines they produce control the inflammatory and cellular
immune responses by influencing the activation and function of T lymphocytes. The
lipid modulators they produce such as PGE2 also play a role in regulating these
responses. Here, we examined the role of PGE2 in D. variabilis saliva on the regulation
of macrophage and fibroblast migration along with macrophage cytokine secretion by
using the PGE2 receptor antagonist AH 6809.
It is well established that there is great similarity in the salivary components
among different tick species. One consistency is the presence of prostaglandins [39,4650], and particularly PGE2 in saliva which has been shown to regulate dendritic cell
differentiation, maturation, and cytokine production [31-32] and inhibit T lymphocyte
proliferation [47]. Our results indicate that D. variabilis saliva like other ixodid tick
species contains a high concentration of PGE2 and stimulates PGE2 production by
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macrophages. Therefore, ticks not only secrete components in their saliva to regulate
host responses but also their salivary components induce cells to produce and secrete
immuno-modulatory, anti-hemostatic, and anti-inflammatory effectors such as PGE2.
PGE2 has been shown to regulate the migratory activity of different cell types
[51,54,65-66]. Therefore it is logical that the PGE2 content in tick saliva is responsible
for our previous observation of the saliva-induced regulation of macrophage [14] and
fibroblast migration [13,15]. We show the increased macrophage migration and
decreased fibroblast migration are both sensitive to the PGE2 receptor antagonist AH
6809. These data are consistent with the studies showing differing effects of PGE2 on
macrophage [51] and fibroblast [52-54] migration. In addition, fibroblasts treated with
conditioned medium from saliva-treated macrophages had lower migratory rates, a
response reversed by AH 6809. AH 6809 fully restored the migratory activity of
fibroblasts treated with conditioned medium from saliva-treated macrophages suggesting
this response was mediated by PGE2. However, AH 6809 partially restored the migration
of the cells treated with saliva only, meaning the saliva-induced inhibition was also
regulated by some other salivary constituent(s). This is supported by our previous studies
which have shown saliva treatment reduced migration in fibroblasts and cancer cells, a
response that correlated with changes in downstream effectors of growth factor receptor
signaling [13,15]. Our results demonstrating that saliva modulates migration in these cells
are further substantiated by studies which identified changes in macrophage [67] and
fibroblast [15] numbers at the feeding lesion.
Whether or not PGE2 is a pro or anti-inflammatory mediator is controversial [4142,59,68-69]. Since it is imperative for ticks to control host responses, we believe the
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PGE2 in saliva dampens host inflammation. From our observation of 22 cytokines, we
show saliva reduces the LPS-stimulated secretion of pro-inflammatory cytokines CCL5,
TNF-α, and soluble TNF Receptor I (sTNFRI). CCL5 recruits macrophages, dendritic
cells, basophils, eosinophils, mast cells, natural killer cells, and T lymphocytes to sites of
inflammation and infection [70-71] where they either participate in resolving
inflammation or provide cues for activation of the adaptive immune response. The
decrease in CCL5 was reversed by the PGE2 receptor antagonist consistent with a report
showing that tumor-secreted PGE2 inhibits CCL5 production in macrophages [60].
However, this reduction in CCL5 may be due to the chemokine binding protein, Evasin4, which interacts with CCL5 and CCL11 and has been identified in tick SGE [19]. By
decreasing CCL5, ticks can prevent macrophages from recruiting other leukocytes to the
feeding lesion, therefore dampening the host inflammatory and immune responses.
Chiefly produced by macrophages, TNF-α is a pleiotropic cytokine that serves as a key
mediator of inflammation. It increases vascular permeability and cytokine production
eliciting the recruitment of macrophages and neutrophils to sites of infection. In
neutrophils, TNF-α has been shown to induce proliferation and apoptosis [72]. It can
also induce blood clotting [73] therefore serving as a mechanism of containment during
an infection. Low levels of TNF-α promote replacement or remodeling of damaged
tissue by triggering fibroblast growth [74]. This cytokine can result in activation of an
adaptive immune response since it contributes to the proliferative response in T
lymphocytes [75]. However, the persistent presence of TNF-α can contribute to chronic
inflammatory conditions as seen in rheumatoid arthritis (RA) [76]. We show saliva
reduces the secretion of TNF-α and its receptor in macrophages, and this effect was
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sensitive to the PGE2 receptor antagonist. This is supported by evidence indicating that in
macrophages PGE2 works in concert with IL-6 to inhibit TNF-α production in a murine
arthritis/lupus model [41]. Surprisingly, saliva did not affect the secretion of IL-6 and IL12p40p70 or the anti-inflammatory cytokine IL-10 (data not shown). We expected saliva
to impose some change on IL-6 secretion because in RA it is considered proinflammatory [41], and it is produced with TNF-α and IL-1β in other stress conditions
[77]. Furthermore, both in vitro [78] and in vivo [77] studies have indicated the antiinflammatory effects of IL-6. Since we have previously shown saliva increases the gene
expression of anti-inflammatory cytokine IL-10 [14] which is indicative of an immune
response shifted toward a T helper 2 phenotype [79], we anticipated saliva would
increase the secretion of this cytokine but this effect was not observed (data not shown).
Saliva did not reduce the IL-12 subunit IL-12p40p70 as we expected because PGE2
inhibits IL-12 production in macrophages [42] and production of this cytokine drives a
pro-inflammatory response characterized as a T helper 1 reaction [80]. However, we are
currently investigating the secretion of these cytokines at earlier time points as in our
gene expression study in Kramer et al. [14]. Also we evaluated how saliva influences the
secretion of pro-inflammatory cytokine IL-1β. The production of this cytokine is tightly
regulated by a multi- protein complex called an inflammasome. While saliva increases
LPS-stimulated secretion of IL-1β, we have shown that the expression of the IL-1β
receptor antagonist IL-1RN is also up-regulated and may serve as a countermeasure to
any pro-inflammatory effects from this cytokine [14].
PGE2 modulates cellular activities via G protein-coupled receptors EP1-4 whose
effects are mediated through calcium mobilization and cAMP production. In fibroblasts,
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PGE2 activation of EP2 and EP4 receptors leads to increases in cAMP production and
inhibition of migration [52-54] comparable to our observation of saliva-induced
decreases in fibroblast migration. We also observed the saliva-induced increases in
cAMP production in macrophages correlated with the PGE 2-mediated changes on
migration and cytokine secretion. Using RAW264.7 macrophages, Tajima et al., [51]
shows that PGE2 regulates LPS-stimulate migration through the EP4 receptor supporting
our rationale for the PGE2 content in tick saliva as the modulator of macrophage
migration. In our study we used the PGE2 receptor antagonist AH 6809 which binds EP2
but not EP4. However, we believe that the ability of AH 6809 to reverse the stimulatory
effects of PGE2 and saliva on macrophage migration suggests that in IC-21 macrophages
EP2 also plays a role. Also intracellular cAMP has been shown to have a central role in
resolving inflammation [81-82]. The inhibitory effects of tumor-secreted PGE2 on
macrophage CCL5 are mediated through cAMP [60] further supporting the idea that
inhibitory effects of saliva on macrophage cytokine secretion are caused by PGE2 and
mediated through cAMP.
Conclusions
To facilitate the feeding process, ticks and other arthropods have evolved a
repository of pharmacologically active molecules in their saliva to modulate the host’s
inflammatory and immune responses. Our data illustrate the saliva-induced changes on
macrophage and fibroblast migration and cytokine secretion in macrophages are sensitive
to a PGE2 receptor antagonist suggesting these effects are mediated at least in part by
PGE2 signaling through the second messenger cAMP. This indicates the PGE2 content in
tick saliva has roles in altering the migratory activity and cytokine profile of cells
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involved inflammation and wounding healing. These findings further demonstrate the
complex nature of tick saliva and highlight the potential redundancy in the mechanisms
utilized to regulate host responses.
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CHAPTER 4
Conclusions
Ixodid ticks molt into each stage of their life cycle after ingesting a blood meal
which can be anywhere from 3-14 days depending on the stage and species. To
complete a blood meal, the tick must attach to the host which requires penetrating the
host’s skin, inserting their mouthparts, rupturing blood vessels, and establishing a feeding
lesion that extends into the dermis of the host. Next a cement-like substance is secreted
from the salivary glands that helps anchor the tick during feeding. Throughout the
feeding process, the tick continuously alternates between ingesting blood and salivating
into the host. Physical attachment to the host for an extended period of time and
completion of the feeding process requires the tick to secrete bioactive molecules in their
saliva that regulate the host’s immune, inflammatory, hemostatic, and wound healing
responses. The data presented in this dissertation indicate that the cocktail of bioactive
molecules in tick saliva have global effects on the function of cancer, immune, and
reparative cells.
Cell migration is a highly integrated multi-step process regulated by different
signaling pathways. Disruption of the effectors in these pathways can prevent normal
physiological events such as tissue repair or lead to the progression of various diseases
like metastatic cancer. In Chapter 2, our findings indicate that D. variabilis saliva
inhibits the migratory activities of Saos-2 osteosarcoma and MDA-MB-231 (MB-231)
breast cancer cells. When comparing the inhibitory effects of saliva on these two cell
lines, the MB-231 cells required a greater concentration of saliva. The differences in the
responsiveness of these cells to saliva appear to be, at least in part, influenced by EGFR
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number as the EGFR is over-expressed in the MB-231 cells. Our evaluation of the
saliva-induced inhibition on Saos-2 and MB-231 migration correlated with decreases in
the activities of the EGFR downstream effectors, ERK and Akt, and is consistent with
observations that both ERK and Akt can regulate the migratory activity of cancer cells
(Liu et al., 2012; Gan et al., 2010; Zhou et al., 2006; Price et al., 1999). In Saos-2 cells,
saliva reduces EGF activation of Akt which has been shown to play an important role in
migration in these cells (Coltella et al., 2003). ERK does not appear to regulate migration
in Saos-2 cells, and saliva had no effect on ERK activity. Basal MB-231 migration is
ERK- dependent while EGF-stimulated migration is PI3K- and PLC-dependent (Price et
al., 1999). Saliva decreases ERK activity in the MB-231 cells; however Akt was not
affected. The inhibitory effect of saliva on ERK activity was comparable to the effects of
the EGFR inhibitor PD 168393 and MEK inhibitor U0126. Since activation of the EGFR
plays a role in cell migration in a number of cells, these data suggest that the EGFR may
be a common target for regulation by constituents in tick saliva.
Wound healing is a normal physiological event in which the host’s tissue repairs
itself after an injury (reviewed in Singer and Clark, 1999). This intricate process consists
of three overlapping phases: inflammatory, proliferative, and remodeling. The
inflammatory phase begins with the initial injury when blood vessels are disrupted
leading to platelet activation, clot formation, and the release of growth factors.
Neutrophils are the predominant cell in the inflammatory phase for the first 48 h of
wound healing. They phagocytose cell debris and bacteria, produce reactive oxygen
species (ROS) to kill bacteria, release cytokines to attract macrophages, and release
proteases to remove bacteria and injured tissue. Neutrophils then undergo apoptosis and
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are phagocytosed by macrophages that prevent the leakage of cytotoxic contents which
result in more damage to the surrounding tissue.
Macrophages are critically important in wound healing since they regulate the
activities of other immune and reparative cells. They arrive at the injury site around day
3, and they phagocytose bacteria, cell debris, red blood cells, and apoptotic neutrophils
becoming the predominant cell in the wound. Macrophages trigger the proliferative
phase by secreting cytokines and growth factors such as PDGF which recruits fibroblast
to the injury. Once the fibroblasts migrate into the wound and become the predominant
cell in the proliferative phase, they proliferate then synthesize and deposit collagen.
Angiogenesis, granulation tissue formation, epithelialization, and wound contraction take
place during the proliferative phase. Fibroblasts secrete growth factors such as vascular
endothelial growth factor (VEGF) that lead to the recruitment of epithelial cells.
Fibroblasts then differentiate into myofibroblasts that continue to migrate across the
wound causing wound contraction. The proliferative phase is followed by collagen
remodeling, in the remodeling phase. Macrophages and fibroblasts have essential roles in
the wound healing response; therefore it would be very beneficial for ticks to utilize their
salivary constituent(s) to delay wound healing by targeting macrophage and fibroblast
function.
Previously, we have shown that tick SGE and saliva modulate the activities of
fibroblasts and macrophages to delay wound healing (Kramer et al., 2011 and 2008).
PGE2 increases macrophage migration (Tajima et al., 2008) and decreases fibroblast
migration (Sandulache et al., 2007 and 2006; Kohyama et al., 2001). Our data are
consistent with these findings as shown in Chapter 3. We show that tick salivary PGE2
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mediates the saliva-induced increase in macrophage migration and the decrease in
fibroblast migration as these effects are reversed by the PGE 2 receptor antagonist, AH
6809. PGE2 regulates fibroblast and macrophage migration via G protein-coupled
receptors EP2/ EP4 which effects are mediated through increases in the second
messenger cAMP. In macrophages, saliva mimics the PGE2-stimulated increase of
antagonist-sensitive intracellular cAMP production. This illustrates that the PGE2 in tick
saliva binds to host cell PGE2 receptors and stimulates cAMP levels affecting fibroblast
and macrophage migration. Collectively, our migration experiments show that the
constituents in tick saliva can target the same physiological event; however, it appears
these responses are mediated through different signaling pathways which commonly
occur. The ability of ticks to utilize their salivary constituents to modulate host responses
by mitigating cell signaling proves to be advantageous for ticks during the feeding
process.
As with reparative cells in wound healing, cellular invasiveness is a crucial
characteristic of a metastatic phenotype. It is related to and encompasses migration but
the cells must also move through the extracellular matrix (ECM) which requires the
production of proteolytic enzymes. In Chapter 2, we show that saliva inhibits the
invasiveness of Saos-2, MB-231, and fibroblasts when stimulated with FBS. However,
saliva inhibited the migration of Saos-2 cells while eliciting a pro-migratory response in
the MB-231 cells when FBS was used as the chemoattractant. We determined saliva had
no effect on cell viability in this study. Since saliva had different effects on FBSstimulated MB-231 and Saos-2 migration, we conclude that the reduction in cell invasion
is not simply a reflection of lower migratory rates. We believe the most likely
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explanation is a decrease in the production of matrix metalloproteinases (MMPs) which
are responsible for ECM degradation. In the MB-231 cells, it has been shown that
agonist-induced activation of (MMP)-9 results in suppressed migration and invasion
(Tsai et al., 2012), and we show saliva decreases the expression of MMP-2 and 9 in
fibroblasts supporting the idea that a salivary constituent(s) reduces MMP activity
(Appendix B).
Another vital role of macrophages is the regulation of the immune responses and
inflammation by secreting cytokines, growth factors, and non-protein molecules that
modulate the activity of immune and reparative cells. Macrophages secrete molecules
such as TNF-α, IL-1β, IL-6, IL-12, IL-10, PDGF, CCL5, and PGE2 and some work in
concert to reduce inflammation. For example, IL-6 decreases the pro-inflammatory
effects of IL-1β by increasing the expression of the IL-1β receptor antagonist (IL 1rn)
and stimulates production of anti-inflammatory IL-10. IL-10 in turns inhibits the
production of other pro-inflammatory cytokines such as TNF-α and IFN-γ. The proinflammatory effects of TNF-α are decreased by PGE2 via EP2/EP4 receptors and IL-6.
We have shown that tick saliva regulates gene expression in macrophages in a manner
consistent with an immune response skewed toward a T helper 2 reaction, that is
characterized by the production of anti-inflammatory cytokines IL-10 and IL-4 (Kramer
et al., 2011). PGE2 reduces CCL5 (Qian et al., 2011) and TNF-α (Akaogi et al., 2004)
secretion in macrophages, an effect mediated by cAMP. In Chapter 3 of this study we
demonstrated that saliva reduces the secretion of TNF-α and the soluble form of its
receptor sTNFRI. Saliva also decreased the secretion of chemokine CCL5. The
reduction of these cytokines by saliva was reversed by AH 6809 and correlated with
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changes in intracellular cAMP production that is associated with resolving inflammation
(Addas et al., 1996; Moore et al., 1995). These observations show the role of salivary
PGE2 in the regulation of macrophage cytokine profile and the consequent effects on
immune and reparative cells in wound healing.
The data in this dissertation indicate that saliva from D. variabilis has global
effects on the migratory activities of different cell types. Even though this regulation is
global, it appears that the constituents in tick saliva can target and modulate different
signaling pathways to regulate the same physiological process. We also illustrate how
one constituent, PGE2, regulates not only migration but the secretion of cytokines. The
redundancy emphasizes the fact that ticks must regulate the cellular population at the
feeding lesion by releasing immuno-modulatory and anti-inflammatory molecules to
control host responses in order to complete a blood meal. Targeting these aspects in
vaccine or drug development could be instrumental in preventing tick attachment or their
modulation of the host responses therefore controlling the occurrence of tick-borne
diseases.
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APPENDICES
Appendix A
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Fig. 1. Heat and protease inactivation of tick saliva prevents its effects on Saos-2
migration. Saos-2 cells were pretreated for 30 min with vehicle (PBS), saliva (0.4 μg
protein/ml), saliva heated for 30 min at 75◦C, or saliva + 0.025% trypsin. The cells were
then placed in blind-well chambers in the presence of FBS. After 4 h, saliva significantly
inhibited Saos-2 migration. This effect was not observed when heat and trypsin were
used to denature the proteins in saliva, (a) p<0.05 when compared to vehicle control.
Data are reported as the % control values and are means + SEM, n=3. These results
suggest a protein (s) in tick saliva is responsible for the saliva-induced inhibition on Saos2 migration. Since PGE2 increases the migratory activity of these cells, this further
supports tick saliva contains different constituents which regulate the same cellular
activities.
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Fig. 2. Tick saliva had no effect on colony formation in Saos-2 cells. To determine if
saliva affects the viability of Saos-2 cells, we used a clonogenic assay which shows the
ability of the cells to divide and form colonies. A 0.5% agarose solution consisting of
Saos-2 feeding medium was poured in 6 well plates as the bottom feeding layer. This
layer was covered with a 0.3% agarose solution with feeding medium and Saos-2 cells at
a density of 5 x 104 cells/ml that were treated with saliva. After 1 week, saliva had no
significant effect (p< 0.05) on Saos-2 colony formation. Data are reported as the %
control values and are means + SEM, n=3. These results in conjuction with the Saos-2
cell number data in Chapter 2 support the conclusion that the saliva-induced decrease on
Saos-2 migration was not due to saliva killing a percentage of the cells.
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Fig. 3. Tick saliva does not affect Akt activity in MDA-MB-231 breast cancer cells.
MDA-MB-231 cells were pretreated with vehicle (PBS) or saliva for 30 min then
challenged with 1, 10 and 100 ng/ml EGF for 15 min. Saliva had no significant effect
(p< 0.05) on EGF-activation of Akt. Data are reported as the fold change from vehicle
treated cells and are means ± SEM, n=3 assayed in triplicate.
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Appendix B
Hard ticks are obligate ectoparasites with a very complex feeding process. After
establishing a specialized feeding lesion, ticks pool feed by alternating between ingesting
blood and secreting saliva into the host (Sonenshine, 1991). For ticks to feed, they must
control the wound healing cascade which involves immune cells, reparative cells,
cytokines, growth factors, and extracellular matrix. In wound healing there are three
overlapping phases: inflammatory phase, proliferative phase, and remodeling phase. The
inflammatory phase begins with the initial injury. Blood vessels are disrupted leading to
platelet activation, clot formation, and the release of growth factors (Singer and Clark,
1999). Consequently in a short period, chemoattractants are released and neutrophils
migrate from the blood vessels to the wound site (Segal, 2005). Neutrophils phagocytose
cell debris and bacteria, produce reactive oxygen species to kill bacteria, release
cytokines to attract macrophages, and release proteases to remove bacteria and injured
tissue (Nathan, 2006). After neutrophils perform their functions in wound healing, they
undergo apoptosis and are phagocytosed by macrophages to limit cytotoxic contents from
spilling and damaging surrounding tissue (Serhan and Savill, 2005; Nishio et al., 2005).
Macrophages trigger the proliferative phase by secreting cytokines and growth factors
such as platelet-derived growth factor which recruits fibroblasts to the injury (Werner and
Grose, 2003). Fibroblasts migrate into the wound were they proliferate, deposit new
collagen, and secrete growth factors (chemoattractants) for other cells involved in the
remodeling phase (Werner and Grose, 2003). Here we examine the saliva-induced
effects on the expression of fibroblast genes involved in the host wound healing response.
We hypothesize that tick saliva will down regulate expression of genes critical to wound
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healing. Our data from PCR arrays show a down-regulation of several integrin and matrix
metalloproteinase genes as well as two collagen genes. In contrast, our data show an upregulation of the gene for collagen, type 1 alpha 1. We conclude, as observed in other
systems, ticks balance pro and anti-inflammatory mechanisms to regulate wound healing.
Materials and methods
Cell culture
NIH3T3-L1 fibroblasts were grown in 100 mm dishes in Dulbecco’s modified
Eagle’s medium nutrient mixture F-12 (DMEM/F12) (MediaTech, Herndon, VA)
supplemented with 10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin, and were
subcultured weekly using Ca2+/Mg2+ free Hank’s balance salt solution (HBSS) and
0.025% trypsin/0.02% EDTA (Mediatech, Herndon, VA) then seeded at a density of 5 x
104 cells/ml.
PCR array
A RT2 ProfilerTM Wound Healing PCR array (SABiosciences-Qiagen, Valencia,
CA) was used to analyze the saliva-induced changes on the expression of fibroblast genes
expected to be modified if saliva regulates wound healing. Fibroblasts were treated with
vehicle (PBS) or saliva (0.4 μg protein/ml) for 2 hr. The cells were lysed with RNA
Lysis Solution with 2-mercaptoethanol, and the RNA was isolated using the PureLink
Micro-to-Midi total RNA Purification System (Gibco-Invitrogen, Carlsbad, CA). 1 μg of
RNA was treated with DNase to remove contaminating genomic DNA, and cDNA was
synthesized using a RT2 1st strand kit (SABiosciences-Qiagen, Valencia, CA). The
template cDNA was characterized for up or down regulation of gene expression using
human primers and RT2 SYBR green Master Mix (SABiosciences-Qiagen, Valencia,
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CA). The data were analyzed as relative changes in gene expression of the control and
experimental groups when compared to the housekeeping gene (GAPDH). Only genes
with 2-fold or greater changes were considered relevant.
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Fig. 1. Tick saliva up-regulates the expression of collagen1a1 in fibroblasts.
Fibroblasts were treated with vehicle (PBS) or saliva (0.4 μg protein/ml) for 2 hr. RNA
was isolated from the treated cells then real-time PCR was performed using cDNA. Tick
saliva up-regulated the expression of the collagen type 1 alpha 1(Col1a1) gene by 2.2
fold in fibroblasts. Saliva decreased the gene expression of collagen type 3 alpha 1
(Col3a1) and collagen type 6 alpha 1 (Col6a1) however the changes were not relevant (2fold or greater) when compared to vehicle treated cells.
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Fig. 2. Tick saliva inhibits the expression of matrix metalloproteinase (MMP) 2 in
fibroblasts. Matrix metalloproteinases (MMPs) degrade the extracellular matrix which
allows fibroblasts to enter the wound site. RNA and real-time PCR were performed as
indicated in Fig. 1. Saliva down-regulated the expression of the MMP 2 gene by 2.5 fold
in fibroblasts treated for 2 h. Saliva decreased the gene expression of MMP 9 and
increased the expression of MMP 13 and MMP 14 but the changes were not relevant (2fold or greater) when compared to vehicle treated cells.
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Fig. 3. Tick saliva up-regulates the expression of integrin alpha 3 (Itga3) and
integrin beta 3 (Itgb3). Integrins are transmembrane receptors which allows cells to
attach to the extracellular matrix and other cells. RNA and real-time PCR were
performed as indicated in Fig. 1. Tick saliva up-regulated the expression of the Itga3
and Itgb3 by 2.1 and 2.0 fold respectively. Saliva induces changes in other integrin
related proteins but the changes in gene expression were not relevant (2-fold or greater)
when compared to vehicle treated cells.
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Fig. 4. Saliva-induced changes in the expression of extracellular matrix proteins.
The integrity of the extracellular matrix, which is important for homeostasis, is
maintained by several proteins. RNA and real-time PCR were performed as indicated in
Fig. 1. Tick saliva decreased the expression of several extracellular matrix proteins but
only extracellular matrix protein 1 (Ecm1) (2.0 fold) and sarcoglycan (Sgce) (2.6 fold)
were relevant when compared to vehicle treated cells. Ecm1 plays a role in angiogensis
and interacts with other extracellular matrix proteins to maintain the intergity of the skin
while Sgce aids in linkage of the cytoskeleton with extracellular matrix.

91

References
Nathan, 2006. Neutrophils and immunity: challenges and opportunities. 6ed. 173-182.
Nishio, N., Okawa, Y., Sakurai, H., Isobe, K., 2005. Neutrophil deletion delays wound
repair in aged mice. Age (Dordr). 30, 11-19.
Segal, A.W., 2005. How neutrophils kill microbes. Annu. Rev. Immunol. 23, 197-223.
Serhan, C.N., Savill, J., 2005. Resolution of inflammation: the beginning programs the
end. Nat. Immunol. 6, 1191-1197.
Singer, A.J., Clark, R.A., 1999. Cutaneous wound healing. N. Engl. J. Med. 341, 738746.
Sonenshine, D.E., 1991. Biology of Ticks. Vol. 1. Oxford University Press, New York.
Werner, S., Grose, R., 2003. Regulation of wound healing by growth factors and
cytokines. Physiol. Rev. 83, 835-870.

92

